X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4191) 4191
Publication (311) 311
Magazine Article (17) 17
Newsletter (15) 15
Book Chapter (12) 12
Book Review (5) 5
Government Document (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3211) 3211
male (2170) 2170
female (2075) 2075
splenomegaly (1401) 1401
adult (1275) 1275
splenomegaly - etiology (1242) 1242
middle aged (1150) 1150
splenomegaly - pathology (1119) 1119
animals (973) 973
spleen - pathology (888) 888
index medicus (859) 859
aged (738) 738
mice (674) 674
liver - pathology (595) 595
adolescent (583) 583
child (506) 506
splenectomy (470) 470
diagnosis, differential (464) 464
splenomegaly - complications (462) 462
hematology (449) 449
bone marrow - pathology (444) 444
spleen (418) 418
pathology (416) 416
hepatomegaly - etiology (383) 383
biopsy (364) 364
splenomegaly - diagnosis (331) 331
child, preschool (326) 326
infant (324) 324
lymph nodes - pathology (305) 305
oncology (275) 275
immunology (265) 265
hepatomegaly (236) 236
diagnosis (230) 230
medicine, general & internal (229) 229
hepatomegaly - pathology (221) 221
splenomegaly - diagnostic imaging (213) 213
anemia (210) 210
liver (210) 210
disease (203) 203
splenomegaly - surgery (202) 202
treatment outcome (199) 199
mice, inbred c57bl (195) 195
tomography, x-ray computed (195) 195
prognosis (191) 191
splenomegaly - immunology (189) 189
pediatrics (188) 188
retrospective studies (184) 184
organ size (172) 172
research article (168) 168
ultrasonography (160) 160
leukocyte count (159) 159
splenomegaly - genetics (158) 158
mutation (155) 155
splenic neoplasms - pathology (152) 152
surgery (150) 150
follow-up studies (141) 141
aged, 80 and over (140) 140
research (140) 140
leukemia (139) 139
time factors (139) 139
liver cirrhosis - pathology (138) 138
lymphocytes (134) 134
infant, newborn (133) 133
analysis (132) 132
gastroenterology & hepatology (132) 132
disease models, animal (131) 131
radiography (130) 130
rats (125) 125
medicine (124) 124
bone marrow (123) 123
hepatomegaly - complications (123) 123
lymphatic diseases - pathology (123) 123
microscopy, electron (118) 118
expression (117) 117
fatal outcome (117) 117
mice, inbred balb c (117) 117
blood cell count (116) 116
children (116) 116
autopsy (115) 115
syndrome (115) 115
mice, knockout (113) 113
spleen - immunology (113) 113
age factors (112) 112
care and treatment (110) 110
health aspects (110) 110
splenomegaly - drug therapy (109) 109
infections (108) 108
article (107) 107
primary myelofibrosis - pathology (107) 107
splenomegaly - chemically induced (107) 107
infection (105) 105
infectious diseases (105) 105
inflammation (104) 104
bone marrow examination (101) 101
immunohistochemistry (101) 101
liver function tests (101) 101
blood (100) 100
chronic disease (100) 100
lymphoma (99) 99
young adult (98) 98
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3487) 3487
French (205) 205
German (166) 166
Spanish (102) 102
Italian (75) 75
Japanese (55) 55
Russian (39) 39
Chinese (20) 20
Polish (19) 19
Portuguese (11) 11
Dutch (10) 10
Hungarian (10) 10
Romanian (9) 9
Swedish (4) 4
Bulgarian (3) 3
Hebrew (3) 3
Slovak (3) 3
Turkish (3) 3
Czech (2) 2
Danish (2) 2
Korean (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Finnish (1) 1
Norwegian (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF IMMUNOLOGY, ISSN 0022-1767, 10/2004, Volume 173, Issue 7, pp. 4744 - 4754
Inflammation in the kidney and other tissues (lung, and salivary and lacrimal glands) is characteristic of MRL-Fas(lpr) mice with features of lupus.... 
MRL-LPR MICE | OP OP MOUSE | M-CSF | IFN-GAMMA | MRL/LPR MICE | OSTEOPETROTIC OP/OP MICE | MESANGIAL CELLS | ACUTE-RENAL-FAILURE | TNF-ALPHA | IMMUNOLOGY | SYSTEMIC AUTOIMMUNITY | Salivary Glands - immunology | Leukocytes - pathology | Salivary Glands - pathology | Spleen - immunology | Apoptosis - genetics | Cell Migration Inhibition | Cytokines - physiology | Lymphatic Diseases - genetics | Mice, Inbred MRL lpr | Chemokines - antagonists & inhibitors | B-Lymphocytes - pathology | Kidney Tubules - pathology | Growth Inhibitors - genetics | Macrophage Colony-Stimulating Factor - genetics | Lupus Nephritis - pathology | Epithelium - pathology | Macrophages - pathology | Splenomegaly - genetics | Complement C3 - metabolism | Macrophage Activation - immunology | Lymphatic Diseases - immunology | Splenomegaly - immunology | Chemokines - physiology | Lacrimal Apparatus - immunology | Splenomegaly - prevention & control | Mice, Transgenic | Lupus Nephritis - immunology | Kidney Glomerulus - pathology | Down-Regulation - genetics | Mice, Knockout | Immunoglobulin Isotypes - biosynthesis | B-Lymphocytes - immunology | Growth Inhibitors - physiology | Lymphatic Diseases - pathology | T-Lymphocytes - immunology | Mice | Kidney Glomerulus - immunology | Immunoglobulin G - metabolism | Lupus Nephritis - prevention & control | Bone Marrow - immunology | Leukopenia - immunology | Macrophage Activation - genetics | Leukopenia - genetics | Macrophage Colony-Stimulating Factor - deficiency | Epithelium - immunology | Kidney Glomerulus - metabolism | T-Lymphocytes - pathology | Lacrimal Apparatus - pathology | Spleen - pathology | Macrophages - immunology | Skin - pathology | Skin - immunology | Kidney Tubules - immunology | Severity of Illness Index | Lung - pathology | Lupus Nephritis - genetics | Growth Inhibitors - deficiency | Mice, Inbred C57BL | Lymphatic Diseases - prevention & control | Leukopenia - pathology | Mice, Inbred C3H | Animals | Apoptosis - immunology | Down-Regulation - immunology | Bone Marrow - pathology | Cytokines - antagonists & inhibitors | Macrophage Colony-Stimulating Factor - physiology | Lung - immunology
Journal Article
Hematology, ISSN 1024-5332, 10/2015, Volume 20, Issue 9, pp. 530 - 537
Journal Article
Best Practice & Research: Clinical Haematology, ISSN 1521-6926, 2015, Volume 28, Issue 4, pp. 193 - 199
Abstract Unusual clinical manifestations and associations with auto-immunity or other systemic disorders are uncommon clinical features of hairy cell leukemia... 
Hematology, Oncology and Palliative Medicine | Rare manifestations | Clinical features | Hairy cell leukemia (HCL) | DIAGNOSIS | LYMPHADENOPATHY | COMPLICATIONS | HEMATOLOGY | Bone and Bones - pathology | Liver - pathology | Lymph Nodes - pathology | Humans | Male | Behcet Syndrome - pathology | Splenomegaly - pathology | Antiphospholipid Syndrome - complications | Thrombocytopenia - complications | Splenomegaly - complications | Splenomegaly - diagnosis | Liver - immunology | Anemia, Hemolytic, Autoimmune - pathology | Lymphatic Diseases - diagnosis | Anemia, Hemolytic, Autoimmune - diagnosis | Female | B-Lymphocytes - pathology | Leukemia, Hairy Cell - pathology | Skin - pathology | Skin - immunology | Leukemia, Hairy Cell - immunology | Antiphospholipid Syndrome - diagnosis | Lymphatic Diseases - immunology | Splenomegaly - immunology | Thrombocytopenia - immunology | Behcet Syndrome - complications | Lymphatic Diseases - complications | Anemia, Hemolytic, Autoimmune - complications | Lymph Nodes - immunology | Thrombocytopenia - pathology | Leukemia, Hairy Cell - diagnosis | Antiphospholipid Syndrome - immunology | B-Lymphocytes - drug effects | Leukemia, Hairy Cell - complications | Antiphospholipid Syndrome - pathology | Anemia, Hemolytic, Autoimmune - immunology | Sex Factors | Lymphatic Diseases - pathology | Thrombocytopenia - diagnosis | Behcet Syndrome - diagnosis | Bone and Bones - immunology | Behcet Syndrome - immunology | Leukemia, Hairy cell
Journal Article
Annals of Hematology, ISSN 0939-5555, 4/2018, Volume 97, Issue 4, pp. 597 - 604
Data are limited in developing countries regarding the clinicopathologic features and response to therapy of chronic myeloid leukemia (CML) in the era of... 
Imatinib | Survey | CML | Medicine & Public Health | Hematology | Oncology | Management | Tunisia | Clinical practice | SURVIVAL | INTERFERON | CHRONIC-PHASE | RECOMMENDATIONS | HEMATOLOGY | EUROPEAN-LEUKEMIANET | Prognosis | Follow-Up Studies | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Middle Aged | Child, Preschool | Male | Antineoplastic Agents - therapeutic use | Practice Patterns, Physicians | Protein Kinase Inhibitors - adverse effects | Splenomegaly - pathology | Leukemia, Myeloid, Accelerated Phase - epidemiology | Young Adult | Imatinib Mesylate - therapeutic use | Leukemia, Myeloid, Accelerated Phase - pathology | Antineoplastic Agents - adverse effects | Imatinib Mesylate - adverse effects | Leukemia, Myeloid, Accelerated Phase - diagnosis | Splenomegaly - etiology | Aged, 80 and over | Adult | Female | Retrospective Studies | Child | Leukemia, Myeloid, Accelerated Phase - drug therapy | Leukemia, Myeloid, Chronic-Phase - drug therapy | Splenomegaly - prevention & control | Leukemia, Myeloid, Chronic-Phase - diagnosis | Leukemia, Myeloid, Chronic-Phase - epidemiology | Tumor Burden - drug effects | Protein Kinase Inhibitors - therapeutic use | Adolescent | Survival Analysis | Aged | Tunisia - epidemiology | Antimitotic agents | Chronic myeloid leukemia | Antineoplastic agents | Epidemiology | Patient outcomes | Analysis | Multivariate analysis | Medical prognosis | Leukemia | Developing countries--LDCs | Index Medicus | Tumor Burden/drug effects | Leukemia, Myeloid, Chronic-Phase/epidemiology | Splenomegaly/prevention & control | Leukemia, Myeloid, Accelerated Phase/epidemiology | Antineoplastic Agents/therapeutic use | Splenomegaly/pathology | Life Sciences | Leukemia, Myeloid, Chronic-Phase/pathology | Antineoplastic Agents/adverse effects | Tunisia/epidemiology | Leukemia, Myeloid, Accelerated Phase/pathology | Leukemia, Myeloid, Chronic-Phase/diagnosis | Leukemia, Myeloid, Chronic-Phase/drug therapy | Splenomegaly/etiology | Human health and pathology | Protein Kinase Inhibitors/adverse effects | Leukemia, Myeloid, Accelerated Phase/drug therapy | Imatinib Mesylate/therapeutic use | Leukemia, Myeloid, Accelerated Phase/diagnosis | Protein Kinase Inhibitors/therapeutic use | Imatinib Mesylate/adverse effects
Journal Article
Blood, ISSN 0006-4971, 04/2008, Volume 111, Issue 7, pp. 3849 - 3858
Journal Article
Blood, ISSN 0006-4971, 07/2015, Volume 126, Issue 3, pp. 386 - 396
Journal Article
Journal of Cutaneous Pathology, ISSN 0303-6987, 12/2017, Volume 44, Issue 12, pp. 1075 - 1079
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2011, Volume 179, Issue 1, pp. 23 - 29
Journal Article
Cancer Cell, ISSN 1535-6108, 2005, Volume 7, Issue 5, pp. 445 - 455
Journal Article
Blood, ISSN 0006-4971, 08/2006, Volume 108, Issue 4, pp. 1158 - 1164
We present results of 2 similarly designed but separate phase 2 studies involving single-agent lenalidomide (CC-5013, Revlimid) in a total of 68 patients with... 
MULTIPLE-MYELOMA | GROWTH-FACTOR-BETA | LOW-DOSE THALIDOMIDE | CC-5013 | MYELOPROLIFERATIVE-DISORDERS | ANGIOGENESIS | ANALOGS | MUTATION | CELL TRANSPLANTATION | MYELODYSPLASTIC-SYNDROMES | HEMATOLOGY | Humans | Male | Primary Myelofibrosis - pathology | Neovascularization, Pathologic - complications | Primary Myelofibrosis - blood | Thrombocytopenia - genetics | Thalidomide - analogs & derivatives | Anemia - genetics | Anemia - drug therapy | Anemia, Myelophthisic - genetics | Time Factors | Splenomegaly - blood | Neutropenia - blood | Thalidomide - adverse effects | Primary Myelofibrosis - complications | Splenomegaly - genetics | Administration, Oral | Anemia, Myelophthisic - pathology | Thrombocytopenia - chemically induced | Thalidomide - administration & dosage | Thrombocytopenia - pathology | Remission Induction | Neovascularization, Pathologic - drug therapy | Anemia, Myelophthisic - complications | Sequence Deletion | Splenomegaly - drug therapy | Anemia - blood | Anemia - pathology | Splenomegaly - pathology | Anemia, Myelophthisic - blood | Neovascularization, Pathologic - blood | Neovascularization, Pathologic - pathology | Janus Kinase 2 | Splenomegaly - complications | Protein-Tyrosine Kinases - genetics | Thrombocytopenia - drug therapy | Neutropenia - pathology | Adult | Female | Neutropenia - chemically induced | Neutropenia - genetics | Primary Myelofibrosis - drug therapy | Proto-Oncogene Proteins - genetics | Thrombocytopenia - blood | Anemia, Myelophthisic - drug therapy | Point Mutation | Anemia - complications | Primary Myelofibrosis - genetics | Platelet Count | Neovascularization, Pathologic - genetics | Aged | Hemoglobins - analysis
Journal Article
eLife, ISSN 2050-084X, 2014, Volume 3
SHARPIN regulates immune signaling and contributes to full transcriptional activity and prevention of cell death in response to TNF in vitro. The inactivating... 
mouse | stem cells | cell biology | dermatitis | inflammation | developmental biology | apoptosis | TNF signaling | LUBAC | ubiquitin | APOPTOSIS | CHRONIC PROLIFERATIVE DERMATITIS | RIP3 KINASE | BIOLOGY | MIXED LINEAGE KINASE | CHAIN ASSEMBLY COMPLEX | DOMAIN-LIKE | LYMPHOTOXIN-ALPHA | NLRP3 INFLAMMASOME | KAPPA-B ACTIVITY | CUTTING EDGE | Receptor-Interacting Protein Serine-Threonine Kinases - metabolism | Inflammation - pathology | Liver - pathology | Nerve Tissue Proteins - deficiency | Caspase 3 - metabolism | Caspase 8 - metabolism | Spleen - drug effects | Receptors, Tumor Necrosis Factor, Type I - metabolism | Inflammation - metabolism | Ubiquitination - drug effects | Liver - drug effects | Receptors, Tumor Necrosis Factor, Type II - metabolism | Cytoprotection - drug effects | Cell Death - drug effects | Spleen - pathology | Fibroblasts - metabolism | Mice, Inbred C57BL | Cells, Cultured | Ubiquitin-Protein Ligases - metabolism | Fibroblasts - pathology | Receptors, Interleukin-1 - metabolism | Nerve Tissue Proteins - metabolism | Dermatitis - pathology | Tumor Necrosis Factor-alpha - pharmacology | Keratinocytes - pathology | Macrophages - metabolism | Animals | Keratinocytes - drug effects | Keratinocytes - metabolism | Fibroblasts - drug effects | Myeloid Cells - metabolism | Heterozygote | Macrophages - drug effects | Receptor-Interacting Protein Serine-Threonine Kinases - deficiency | Myeloid Cells - pathology | Chronic Disease | Dermatitis - metabolism | Tumor necrosis factor receptors | Splenomegaly | Transcription | Liver | Lethality | Kinases | Dermatitis | Inflammatory diseases | Proteins | Genotype & phenotype | Immunology | Clonal deletion | Interleukin 1 | Tumor necrosis factor-TNF | Peyer's patches | Medical research | Cytokines | Glycerol | Caspase | Inflammation | Heterozygosity | Caspase-8 | Tumor necrosis factor | Cell death | Cancer | Apoptosis
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 143, Issue 3, pp. 646 - 654
Journal Article